How Much Can You Lose Weight on Ozempic?

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has emerged as one of the most effective weight loss medications available today. In the landmark STEP clinical trials, participants achieved average weight reductions of 15-22% of their starting body weight over 68 weeks of treatment. However, your personal results depend on how well your body responds to the medication, and that response is partly determined by your genetics.

Average Semaglutide Weight Loss Results from Clinical Evidence

The STEP 1 trial enrolled 1,961 adults with obesity and followed them for 68 weeks. Participants receiving semaglutide 2.4 mg weekly lost an average of 10.5 kg (about 23 pounds), or roughly 10.2% of their starting body weight, compared to 2.6 kg (5.7 pounds) in the placebo group. This double-blind, randomized trial established semaglutide as a clinically meaningful treatment for weight management in patients without diabetes.

STEP 2, which studied adults with type 2 diabetes, showed similar or greater effectiveness. Participants lost an average of 6.2 kg (13.7 pounds) or about 6.5% of baseline weight, despite the added metabolic complexity of diabetes. STEP 3 and STEP 4 extended these findings, demonstrating that weight loss is maintained when patients continue treatment and that discontinuation typically results in weight regain.

Why Individual Results Vary: The Role of Genetics in Weight Loss Response

The PlexusDx Precision Peptide Genetic Test analyzes GIPR and FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Lifestyle factors also matter significantly. People who combine semaglutide with consistent physical activity, balanced nutrition, and adequate sleep typically achieve greater weight loss than those relying on medication alone. Adherence to the treatment regimen, regular dose escalation (when appropriate), and honest conversations with your care provider about side effects all influence long-term outcomes.

Realistic Timelines: When to Expect Weight Loss on Semaglutide

Most people begin noticing appetite suppression within the first 1-2 weeks of starting semaglutide, though measurable weight loss typically appears by week 4-6. The medication works by slowing gastric emptying, activating satiety centers in the brain, and reducing cravings for calorie-dense foods. Initial weight loss is often water weight and glycogen depletion; fat loss accelerates as weeks progress and healthy eating habits stabilize.

Maximum weight loss is generally achieved between 16-20 weeks of consistent treatment at therapeutic doses (1.7-2.4 mg weekly for weight management). Participants in STEP trials continued losing weight through 68 weeks, though the rate of loss slowed after the first 4-6 months. PlexusDx Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan), with your dose able to increase as your body adjusts—the pricing stays flat no matter how your therapy evolves.

Maximizing Your Semaglutide Results with Personalized Dosing and Genetic Insight

The standard semaglutide dosing protocol begins at 0.25 mg weekly and escalates by 0.25 mg every four weeks until reaching a therapeutic dose of 2.0-2.4 mg. However, some patients respond optimally at lower doses, while others benefit from sustained doses or require adjustment based on gastrointestinal tolerance and weight loss plateau. PlexusDx providers use clinical monitoring, patient feedback, and—optionally—Precision Peptide Genetic Test results to tailor your regimen for maximum efficacy and minimal side effects.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx Semaglutide Injection: Compounded, Accessible, and Affordable

PlexusDx partners with licensed 503A compounding pharmacies across all 50 states to deliver pharmaceutical-grade compounded semaglutide. Unlike telehealth platforms that mark up brand-name medications, PlexusDx focuses on quality compounding at transparent, flat-rate pricing: Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan), and your dose may increase without your price changing. No insurance is required, no membership fees apply, and your treatment is HSA/FSA eligible.

Access to semaglutide through PlexusDx also includes ongoing provider support, adherence tracking, and the option to add genetic testing to optimize your personal protocol. Because every patient's weight loss journey is unique, PlexusDx emphasizes partnership with your care team, realistic goal-setting, and compassionate, evidence-based treatment. Whether you're starting your first injection or refining your dose after three months, PlexusDx maintains the same commitment to your success.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How much weight can I realistically lose with semaglutide in three months?

Most patients lose 3-8 pounds per month during the first three months, totaling 9-24 pounds by week 12 if adherent to treatment and lifestyle changes. This varies widely based on starting weight, genetics, diet quality, and exercise consistency. Your PlexusDx provider can give a more personalized estimate after your first follow-up visit.

Is 15-22% weight loss the maximum I can achieve?

The STEP trials measured 15-22% average weight loss, but individual results range from 5% to 30%+ depending on baseline metabolism, genetic response, adherence, and lifestyle effort. Some patients maintain their loss indefinitely; others who discontinue regain weight over time.

Does PlexusDx semaglutide work the same way as the brand-name version?

Yes. PlexusDx Semaglutide Injection is compounded by licensed 503A pharmacies to the same pharmaceutical specifications as brand medications. The active compound, semaglutide, is identical; your results depend on dose, consistency, and your body's response—not the source.

What happens to my weight if I stop semaglutide?

Most people regain 50-70% of lost weight within one year of stopping semaglutide, because the underlying hunger and metabolic changes return to baseline. This is why semaglutide works best as ongoing therapy, not a temporary fix.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Ozempic For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.